Literature DB >> 10993460

Incidence of vestibular schwannoma in Denmark, 1977-1995.

M F Howitz1, C Johansen, M Tos, S Charabi, J H Olsen.   

Abstract

OBJECTIVE: To establish the incidence rate of vestibular schwannomas (VS) (acoustic neuromas) in Denmark.
BACKGROUND: The worldwide incidence rates of VS vary from 1 to 20 cases per million population per year.
METHODS: The nationwide and population-based age-specific, sex-specific, and calendar year-specific incidence rates of VS in Denmark between 1977 and 1995 are presented. Information on cases of VS was obtained from the Danish Cancer Registry and a clinical database situated at the University Hospital of Gentofte. A total of 795 cases were reported during the period of the study.
RESULTS: The incidence rate increased from 5 cases per million population per year in 1977-1981 to 10 cases in 1992-1995; the increase was from 5 to 11 cases among women and 5 to 9 cases among men. The age-specific incidence rates show that VS is rarely diagnosed in persons under 30, but the incidence rate appears to increase among women after menopause.
CONCLUSION: The overall incidence rate of VS increased linearly during the study period, probably owing to the introduction of more precise diagnostic procedures, increased awareness among physicians and patients of the symptoms of VS, improved registration of benign tumors in Denmark, and the use of data from two sources.

Entities:  

Mesh:

Year:  2000        PMID: 10993460

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  22 in total

1.  Fundus obliteration and facial nerve outcome in vestibular schwannoma surgery.

Authors:  Vincent Van Rompaey; Joost van Dinther; Andrzej Zarowski; Erwin Offeciers; Thomas Somers
Journal:  Skull Base       Date:  2011-03

2.  Incidence of vestibular schwannomas in the United States.

Authors:  Varun R Kshettry; Jason K Hsieh; Quinn T Ostrom; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2015-05-30       Impact factor: 4.130

3.  Clinicoradiological and surgical considerations in the treatment of cholesterol granuloma of the petrous pyramid.

Authors:  Ulrike Bockmühl; Hisham S Khalil; Wolfgang Draf
Journal:  Skull Base       Date:  2005-11

4.  Expectant management of vestibular schwannoma: a retrospective multivariate analysis of tumor growth and outcome.

Authors:  Mark Hughes; Christopher Skilbeck; Shakeel Saeed; Robert Bradford
Journal:  Skull Base       Date:  2011-09

5.  Descriptive epidemiology of vestibular schwannomas.

Authors:  Jennifer M Propp; Bridget J McCarthy; Faith G Davis; Susan Preston-Martin
Journal:  Neuro Oncol       Date:  2006-01       Impact factor: 12.300

6.  Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.

Authors:  D G R Evans; E R Maher; M E Baser
Journal:  J Med Genet       Date:  2005-08       Impact factor: 6.318

7.  An in vitro model system to study gene therapy in the human inner ear.

Authors:  B W Kesser; G T Hashisaki; K Fletcher; H Eppard; J R Holt
Journal:  Gene Ther       Date:  2007-06-14       Impact factor: 5.250

8.  Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England.

Authors:  Ramandeep S Arora; Robert D Alston; Tim O B Eden; Edward J Estlin; Anthony Moran; Jillian M Birch
Journal:  Neuro Oncol       Date:  2008-11-24       Impact factor: 12.300

9.  Vertigo in Vestibular Schwannoma Patients Due to Other Pathologies.

Authors:  Ronald Sahyouni; Omid Moshtaghi; Yarah M Haidar; Hossein Mahboubi; Afsheen Moshtaghi; Harrison W Lin; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2017-12       Impact factor: 2.311

10.  Probabilistic Fiber-Tracking Reveals Degeneration of the Contralateral Auditory Pathway in Patients with Vestibular Schwannoma.

Authors:  S M Rueckriegel; G A Homola; M Hummel; N Willner; R-I Ernestus; C Matthies
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-02       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.